TD Cowen Forecasts Strong Price Appreciation for Versigent (NYSE:VGNT) Stock

Key Points

• TD Cowen raised its price target on Versigent from $58 to $59 and maintained a Buy rating, implying 46.44% upside from the cited share price of $40.29.
• Versigent beat quarterly expectations, reporting EPS of $1.91 versus $1.79 forecast and revenue of $2.45 billion versus $2.42 billion forecast.
• Analyst sentiment is broadly positive: 11 analysts rate the stock Buy, two Hold, and one Sell, for a Moderate Buy consensus and an average target of $55.08.

Versigent (NYSE:VGNT - Get Free Report) had its price target raised by equities research analysts at TD Cowen from $58.00 to $59.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. TD Cowen's price target would indicate a potential upside of 46.44% from the company's current price.

Several other equities analysts also recently weighed in on the stock. Argus raised their target price on shares of Versigent from $50.00 to $54.00 and gave the company a "buy" rating in a report on Thursday, August 13th. Weiss Ratings raised shares of Versigent from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, October 8th. Zacks Research downgraded shares of Versigent from a "hold" rating to a "strong sell" rating in a report on Thursday, October 15th. Royal Bank Of Canada lowered their price target on shares of Versigent from $53.00 to $52.00 and set an "outperform" rating on the stock in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $54.00 price objective on shares of Versigent in a research report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $55.08.

Versigent Price Performance

VGNT traded down $1.68 during trading on Thursday, reaching $40.29. 967,057 shares of the stock were exchanged, compared to its average volume of 1,522,779. The business's 50 day moving average price is $45.08 and its two-hundred day moving average price is $42.71. The company has a debt-to-equity ratio of 7.29, a current ratio of 1.40 and a quick ratio of 1.09. The company has a market capitalization of $2.85 billion and a price-to-earnings ratio of 20.98. Versigent has a 1 year low of $26.34 and a 1 year high of $50.88.

Versigent (NYSE:VGNT - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.79 by $0.12. The firm had revenue of $2.45 billion during the quarter, compared to analyst estimates of $2.42 billion. As a group, equities research analysts anticipate that Versigent will post 7.23 earnings per share for the current year.

Insider Transactions at Versigent

In other Versigent news, Director Kevin Clark sold 74,130 shares of the firm's stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $45.67, for a total transaction of $3,385,517.10. Following the sale, the director directly owned 124,849 shares of the company's stock, valued at $5,701,853.83. This trade represents a 37.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last 90 days, insiders have sold 220,000 shares of company stock valued at $10,065,848.

Institutional Trading of Versigent

Hedge funds have recently bought and sold shares of the company. Allianz Asset Management GmbH purchased a new position in shares of Versigent in the 2nd quarter worth $20,602,000. HBK Investments L P purchased a new stake in Versigent during the second quarter valued at about $14,439,000. Steamboat Capital Partners LLC purchased a new stake in Versigent during the second quarter valued at about $10,385,000. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Versigent by 321.3% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 242,425 shares of the company's stock valued at $10,895,000 after acquiring an additional 184,888 shares during the period. Finally, WINTON GROUP Ltd acquired a new stake in Versigent during the second quarter worth about $8,397,000.

Key Versigent News

Here are the key news stories impacting Versigent this week:

• Positive Sentiment: Versigent reported third-quarter revenue of $2.45 billion, up 7.2% year over year, and EPS of $1.91 versus the $1.79 consensus estimate. The revenue figure also exceeded expectations of $2.42 billion. Versigent Reports Third Quarter 2026 Results
• Positive Sentiment: The company declared a quarterly dividend of $0.13 per share, equivalent to $0.52 annually and a yield of about 1.2%. Versigent dividend announcement
• Neutral Sentiment: Royal Bank of Canada and BNP Paribas Exane each maintained an “outperform” rating, while trimming their price targets by $1, to $52 and $54, respectively. The targets still indicate substantial potential upside from the cited $40.29 share price. RBC rating BNP Paribas Exane rating
• Neutral Sentiment: CFO Doug Ostermann is scheduled to participate in a fireside chat at the RBC Capital Markets Global Industrials Conference on November 17; the announcement provides no new financial guidance. Conference announcement
• Negative Sentiment: Despite reported sales growth, Versigent’s adjusted net sales growth was only about 1% year over year, suggesting underlying growth was modest. The small target reductions from both banks may also weigh on sentiment. Quarterly results

Versigent Company Profile

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.